Cargando…
Haemodialysed patient with lung cancer in the COVID-19 era: a clinical challenge
A 66-year-old man was referred to the oncological pneumology consultation due to a mass in the right upper lobe observed in a routine X-ray of the chest. The CT scan confirmed a mass in the same location. The biopsy revealed a lung adenocarcinoma. It was decided to start chemotherapy adapted to kidn...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323347/ https://www.ncbi.nlm.nih.gov/pubmed/34326113 http://dx.doi.org/10.1136/bcr-2021-243462 |
_version_ | 1783731224068489216 |
---|---|
author | Carvalho, Tomás de Paiva Trinca, Francisco Cardoso, Teresa Dinis, Rui |
author_facet | Carvalho, Tomás de Paiva Trinca, Francisco Cardoso, Teresa Dinis, Rui |
author_sort | Carvalho, Tomás de Paiva |
collection | PubMed |
description | A 66-year-old man was referred to the oncological pneumology consultation due to a mass in the right upper lobe observed in a routine X-ray of the chest. The CT scan confirmed a mass in the same location. The biopsy revealed a lung adenocarcinoma. It was decided to start chemotherapy adapted to kidney function. In April 2020, the patient contracted SARS-CoV-2 infection and developed bilateral pneumonia with partial respiratory failure. He was transferred to the intensive care unit, where he had a positive evolution. In the next 5 months, there was a clinical improvement; however, the CT scan of the chest showed disease progression. After a new multidisciplinary approach, it was decided to start a second line with atezolizumab. After four cycles of atezolizumab, there was a clear clinical improvement, and a reduction by more than 50% in the tumour size, without significant adverse effects. |
format | Online Article Text |
id | pubmed-8323347 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-83233472021-08-19 Haemodialysed patient with lung cancer in the COVID-19 era: a clinical challenge Carvalho, Tomás de Paiva Trinca, Francisco Cardoso, Teresa Dinis, Rui BMJ Case Rep Case Report A 66-year-old man was referred to the oncological pneumology consultation due to a mass in the right upper lobe observed in a routine X-ray of the chest. The CT scan confirmed a mass in the same location. The biopsy revealed a lung adenocarcinoma. It was decided to start chemotherapy adapted to kidney function. In April 2020, the patient contracted SARS-CoV-2 infection and developed bilateral pneumonia with partial respiratory failure. He was transferred to the intensive care unit, where he had a positive evolution. In the next 5 months, there was a clinical improvement; however, the CT scan of the chest showed disease progression. After a new multidisciplinary approach, it was decided to start a second line with atezolizumab. After four cycles of atezolizumab, there was a clear clinical improvement, and a reduction by more than 50% in the tumour size, without significant adverse effects. BMJ Publishing Group 2021-07-29 /pmc/articles/PMC8323347/ /pubmed/34326113 http://dx.doi.org/10.1136/bcr-2021-243462 Text en © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. https://bmj.com/coronavirus/usageThis article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. |
spellingShingle | Case Report Carvalho, Tomás de Paiva Trinca, Francisco Cardoso, Teresa Dinis, Rui Haemodialysed patient with lung cancer in the COVID-19 era: a clinical challenge |
title | Haemodialysed patient with lung cancer in the COVID-19 era: a clinical challenge |
title_full | Haemodialysed patient with lung cancer in the COVID-19 era: a clinical challenge |
title_fullStr | Haemodialysed patient with lung cancer in the COVID-19 era: a clinical challenge |
title_full_unstemmed | Haemodialysed patient with lung cancer in the COVID-19 era: a clinical challenge |
title_short | Haemodialysed patient with lung cancer in the COVID-19 era: a clinical challenge |
title_sort | haemodialysed patient with lung cancer in the covid-19 era: a clinical challenge |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323347/ https://www.ncbi.nlm.nih.gov/pubmed/34326113 http://dx.doi.org/10.1136/bcr-2021-243462 |
work_keys_str_mv | AT carvalhotomasdepaiva haemodialysedpatientwithlungcancerinthecovid19eraaclinicalchallenge AT trincafrancisco haemodialysedpatientwithlungcancerinthecovid19eraaclinicalchallenge AT cardosoteresa haemodialysedpatientwithlungcancerinthecovid19eraaclinicalchallenge AT dinisrui haemodialysedpatientwithlungcancerinthecovid19eraaclinicalchallenge |